Cargando…
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus
We are currently faced with a global infectious disease crisis which has been anticipated for decades. While many promising biotherapeutics are being tested, the search for a small molecule has yet to deliver an approved drug or therapeutic for the Ebola or similar filoviruses that cause haemorrhagi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000Research
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304229/ https://www.ncbi.nlm.nih.gov/pubmed/25653841 http://dx.doi.org/10.12688/f1000research.5741.2 |